Loading...

STAA STAAR SURGICAL CO Capital Structure Changes 8-K Filing

STR

ST

STAAR SURGICAL CO

(STAA)

2025 8-K

Show Summary

Summary

Investor Meetings

Financial Statements

Leadership Changes

Leadership Change

Financial Results

Earnings Announcement

Financial Update

Quarterly Results

Earnings Reports

Annual Meeting Approval

Presentation to Investors

Appointment of Directors

Conference Call

Earnings Reports

Financial Results and Inves...

Board of Directors Appointm...

Investor Meetings

Conference Call

Earnings Reports

Investor Meetings

Presentation to Investors

Conference Call

Earnings Reports

Annual Meeting Results

Participation in Conference

Investor Meetings

Conference Call

Earnings Reports

Appointment of COO

Investor Meetings

Conference Call

Financial Results Announcement

Bylaws Amendment

Financial Results

External Links:

On May 16, 2025, STAAR Surgical Company announced a $30 million share repurchase program and reported that the EVO+ Toric Implantable Collamer Lens was approved for sale in China on May 14, 2025, aiding in myopia correction for patients aged 21-45.

AI Assistant

STAAR SURGICAL CO

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.